<p>The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.</p>
申请公布号
MX2011001367(A)
申请公布日期
2011.06.28
申请号
MX20110001367
申请日期
2009.08.07
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
PLAMONDON, LOUIS;ZHOU, JINGYE;XIAO, XIAO-YI;HUNT, DIANA, KATHARINE;CLARK, ROGER, B.;ZAHLER, ROBERT, B.
